| Total N = 160 | CKD-ND N = 102 | PD N = 8 | HD N = 40 | Transplant N = 10 |
---|---|---|---|---|---|
Age | |||||
 Mean ± SD | 66.74 ± 15.36 | 68.31 ± 14.43 | 63.38 ± 17.73 | 68.68 ± 13.43 | 45.70 ± 16.08 |
 Median (IQR) | 69 (60,78) | 70 (62,79) | 66.5 (59.3,73.3) | 71.5 (61.3,79.5) | 48 (29,58.5) |
Sex M/F, n(%) | 92/68 (57.5/42.5) | 56/46 (54.9/45.1) | 5/3 (62.5/37.5) | 26/14 (65/35) | 5/5 (50/50) |
eGFR | Â | Â | Â | Â | Â |
 Mean ± SD | NA | 37.23 ± 24.67 |  NA |  NA | 64.8 ± 23.08 |
 Median (IQR) |  | 33 (17,49.25) |  |  | 64.5 (44.3,84.5) |
Cause of CKD, n(%)Â | |||||
 Diabetic | 68 (42.5) | 48 (47.1) | 2 (25) | 16 (40) | 2 (20) |
 Unknown etiology | 23 (14.4) | 12 (11.8) |  | 9 (22.5) | 2 (20) |
 Glomerulonephritis | 24 (15) | 12 (11.8) | 4 (50) | 5 (12.5) | 3 (30) |
 PKD | 9 (5.6) | 4 (3.9) |  | 5 (12.5) |  |
 TIN | 9 (5.6) | 8 (7.9) |  | 1 (2.5) |  |
 NS/Vascular | 9 (5.6) | 7 (6.9) | 2 (25) |  |  |
 One kidney/FSGS | 8 (5) | 6 (5.9) |  | 2 (5) |  |
 Obstructive | 2 (1.3) |  |  |  | 2 (20) |
 Nephronophtisis | 2 (1.3) |  |  | 1 (2.5) | 1 (10) |
 Others | 6 (3.8) | 5 (4.9) |  | 1 (2.5) |  |
CKD stages | |||||
 Stage 1 |  | 7 (6.9) |  |  |  |
 Stage 2 | NA | 8 (7.8) | NA | NA | NA |
 Stage 3a |  | 13 (12.7) |  |  |  |
 Stage 3b |  | 29 (28.4) |  |  |  |
 Stage 4 |  | 28 (27.5) |  |  |  |
 Stage 5 ND |  | 17 (16.7) |  |  |  |
Diabetes, n(%) | 79 (49.4) | 58 (56.9) | 2 (25) | 16 (40) | 3 (30) |
Hypertension, n(%) | 148 (92.5) | 95 (93.1) | 7 (87.5) | 37 (92.5) | 9 (90) |
CAD, n(%) | 50 (31.3) | 35 (34.3) | 2 (25) | 12 (30) | 1 (10) |
Smoking, n(%) | 54 (33.8) | 44 (43.1) | 3 (37.5) | 6 (15) | 1 (10) |
Number of medications per day | |||||
 Mean ± SD | 8.75 ± 3.38 | 8.47 ± 3.74 | 10.38 ± 2.83 | 9.3 ± 2.31 | 8.1 ± 3.2 |
 Median (IQR) | 9 (7,11) | 8 (6,11) | 9 (8.25,12.5) | 10 (8,10) | 7.5 (5.75,10.25) |
Frequency of blood tests per year | |||||
 Mean ± SD | 6.86 ± 6.4 | 3.49 ± 1.72 | 4 ± 1.19 | 16.5 ± 5.36 | 4.9 ± 3.48 |
 Median (IQR) | 4 (3,12) | 3 (2,4) | 4.5 (3,5) | 15 (13,18) | 3.5 (3,6) |
Number of hospitalizations | Â | Â | Â | Â | Â |
 Mean ± SD | 0.79 ± 1.43 | 0.5 ± 0.9 | 1 ± 2.07 | 1.65 ± 2.08 | 0.1 ± 0.31 |
 Median (IQR) | 0 (0,1) | 0 (0,1) | 0 (0,1) | 1 (0,3) | 0 (0,0) |
Third-Party Payer, n(%) | Â | Â | Â | Â | Â |
 NSSF | 79 (49.4) | 48 (47.1) | 3 (37.5) | 21 (52.5) | 7 (70) |
 MOPH | 13 (8.1) | 1 (1) |  |  |  |
 CSC | 12 (7.5) | 9 (8.8) |  | 3 (7.5) |  |
 ISF | 2 (1.3) | 2 (2) |  |  |  |
 Insurance | 25 (15.6) | 25 (24.5) |  |  |  |
 Army | 3 (1.9) | 3 (2.9) |  |  |  |
 NSSF + Insurance | 14 (8.8) | 9 (8.8) | 3 (37.5) | 5 (12.5) |  |
 MOPH + Insurance | 8 (5) | 1 (1) |  | 2 (5) | 2 (20) |
 Out-of-pocket | 3 (1.9) | 3 (2.9) |  |  |  |
 OOP + MOPH | 1 (0.6) | 1 (1) | 2 (25) | 9 (22.5) | 1 (10) |